A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-beta/Smad4 signaling pathway - PubMed (original) (raw)
Review
A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-beta/Smad4 signaling pathway
Shane Holloway et al. Int J Gastrointest Cancer. 2003.
Abstract
Genetic alterations impacting the TGF-beta/Smad4 pathway are found in nearly all pancreatic adenocarcinomas, and recent reports have identified a relationship between DPC4/Smad4 expression and patient survival. In this study we use a clinically relevant animal model of pancreatic cancer to examine the impact of these genetic changes on the biology of pancreatic cancer.
Methods: Using high-density oligonucleotide DNA microarray technology, a comprehensive examination of the components of the TGF-beta/Smad4 pathway was performed on three human pancreatic adenocarcinoma cell lines. The in vitro and in vivo growth characteristics of these cell lines was then compared. Finally, using a clinically relevant orthotopic xenograft model of pancreatic cancer, primary tumor growth and metastases were measured for pancreatic tumors derived from each cell line.
Results: Examination of the TGF-beta/Smad4 pathway components identified that these three cell lines possess molecular profiles consistent with approximately 90% of pancreatic adenocarcinoma tumors in patients. A significant discrepancy between in vitro and in vivo growth characteristics of each cell line was identified. When tumors from each cell line were established in nu/nu mice, each cell line exhibited distinct metastatic profiles. Data from these studies is consistent, with clinical observations concerning DPC4/Smad4 and patient outcome.
Conclusion: Using an orthotopic model of tumor growth and metastasis identifies distinct metastatic profiles associated with molecular alterations of the TGF-beta/Smad4 pathway and provides insight with regard to the biologic consequences of these changes.
Similar articles
- Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K, Ahmed MM, Mohiuddin M, Swiderski C, Lee E, Gower WR Jr, Salhab KF, McGrath P, Strodel W, Freeman JW. Venkatasubbarao K, et al. Anticancer Res. 2000 Jan-Feb;20(1A):43-51. Anticancer Res. 2000. PMID: 10769633 - Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B, Fleming JB, Breslin T, Grau AM, Fojioka S, Abbruzzese JL, Evans DB, Ayers D, Wathen K, Wu T, Robertson KD, Chiao PJ. Peng B, et al. Clin Cancer Res. 2002 Nov;8(11):3628-38. Clin Cancer Res. 2002. PMID: 12429655 - Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
Jazag A, Ijichi H, Kanai F, Imamura T, Guleng B, Ohta M, Imamura J, Tanaka Y, Tateishi K, Ikenoue T, Kawakami T, Arakawa Y, Miyagishi M, Taira K, Kawabe T, Omata M. Jazag A, et al. Oncogene. 2005 Jan 20;24(4):662-71. doi: 10.1038/sj.onc.1208102. Oncogene. 2005. PMID: 15592526 - DPC4/SMAD4 gene alterations in human cancer, and their functional implications.
Schutte M. Schutte M. Ann Oncol. 1999;10 Suppl 4:56-9. Ann Oncol. 1999. PMID: 10436786 Review. - Smad4 transcriptional pathways and angiogenesis.
Schwarte-Waldhoff I, Schmiegel W. Schwarte-Waldhoff I, et al. Int J Gastrointest Cancer. 2002;31(1-3):47-59. doi: 10.1385/IJGC:31:1-3:47. Int J Gastrointest Cancer. 2002. PMID: 12622415 Review.
Cited by
- Effect of deleted pancreatic cancer locus 4 gene transfection on biological behaviors of human colorectal carcinoma cells.
Xiao DS, Wen JF, Li JH, Hu ZL, Zheng H, Fu CY. Xiao DS, et al. World J Gastroenterol. 2005 Jan 21;11(3):348-52. doi: 10.3748/wjg.v11.i3.348. World J Gastroenterol. 2005. PMID: 15637742 Free PMC article. - Hemoglobin-based oxygen carrier mitigates transfusion-mediated pancreas cancer progression.
Lo KK, Bey EA, Patra B, Benson DD, Boothman DA, Silliman CC, Barnett CC Jr. Lo KK, et al. Ann Surg Oncol. 2013 Jun;20(6):2073-7. doi: 10.1245/s10434-012-2842-0. Epub 2013 Jan 18. Ann Surg Oncol. 2013. PMID: 23328973 Free PMC article. - Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice.
Barnett CC Jr, Beck AW, Holloway SE, Kehler M, Schluterman MK, Brekken RA, Fleming JB, Silliman CC. Barnett CC Jr, et al. Cancer. 2010 Aug 15;116(16):3862-74. doi: 10.1002/cncr.25140. Cancer. 2010. PMID: 20564095 Free PMC article. - Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserved Heterogeneity in Culture.
Pham K, Delitto D, Knowlton AE, Hartlage ER, Madhavan R, Gonzalo DH, Thomas RM, Behrns KE, George TJ Jr, Hughes SJ, Wallet SM, Liu C, Trevino JG. Pham K, et al. Am J Pathol. 2016 Jun;186(6):1537-46. doi: 10.1016/j.ajpath.2016.02.009. Epub 2016 Apr 18. Am J Pathol. 2016. PMID: 27102771 Free PMC article. - Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy.
Zhao J, Wang H, Hsiao CH, Chow DS, Koay EJ, Kang Y, Wen X, Huang Q, Ma Y, Bankson JA, Ullrich SE, Overwijk W, Maitra A, Piwnica-Worms D, Fleming JB, Li C. Zhao J, et al. Biomaterials. 2018 Mar;159:215-228. doi: 10.1016/j.biomaterials.2018.01.014. Epub 2018 Jan 9. Biomaterials. 2018. PMID: 29331808 Free PMC article.
References
- Clin Cancer Res. 2002 Nov;8(11):3628-38 - PubMed
- Genes Dev. 1995 Aug 1;9(15):1831-45 - PubMed
- Oncogene. 2002 Sep 5;21(39):6049-58 - PubMed
- Genetics. 1995 Mar;139(3):1347-58 - PubMed
- Biochim Biophys Acta. 1996 Mar 18;1242(3):185-99 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous